Dr. Brian Lichty is featured in this Oxford University Press blog post on T-Vec – a modified form of the herpes simplex type 1 virus approved for melanoma treatment.
Featured image credit: Metastatic Melanoma Cells by Julio C. Valencia. Public Domain via Wikimedia Commons
Author:
admin